Evidence-based profiles for every peptide in our research library
A modified fragment of human growth hormone (amino acids 177-191) that stimulates lipolysis without the diabetogenic or growth-promoting effects of full GH.
A 15-amino-acid peptide derived from human gastric juice with remarkable tissue-healing properties across tendons, ligaments, muscle, gut, and brain.
A porcine brain-derived peptide preparation containing neurotrophic factors that mimic the activity of BDNF and NGF, approved in over 40 countries for stroke and dementia.
A modified growth-hormone-releasing hormone analog with extended half-life that amplifies natural GH pulsatility.
A neuromodulatory nonapeptide that promotes physiologic delta-wave sleep patterns and modulates stress-related endocrine function.
A synthetic tetrapeptide based on the pineal gland's epithalamin that activates telomerase and may slow cellular aging.
A naturally occurring copper-binding tripeptide that promotes wound healing, collagen synthesis, and tissue remodeling.
A potent hexapeptide growth hormone secretagogue that stimulates GH release through the ghrelin receptor, with secondary effects on cortisol and prolactin.
One of the earliest synthetic growth hormone secretagogues, potently stimulating GH release and appetite through the ghrelin receptor but with less selectivity than newer alternatives.
The body's master antioxidant — a tripeptide critical for detoxification, immune defense, and protection against oxidative stress.
A synthetic gonadotropin-releasing hormone used to stimulate LH and FSH production for fertility and hormonal support.
A selective growth hormone secretagogue that stimulates GH release from the pituitary without significantly affecting cortisol or prolactin.
A hypothalamic neuropeptide that acts as the master upstream regulator of the reproductive hormone cascade by stimulating GnRH neurons.
A potent anti-inflammatory tripeptide derived from the C-terminus of alpha-MSH that suppresses NF-kB signaling without melanocortin receptor activation.
The only human cathelicidin antimicrobial peptide, providing broad-spectrum antimicrobial activity and immune modulation as part of the innate immune system.
A non-selective melanocortin receptor agonist that induces skin tanning, appetite suppression, and sexual arousal, but carries significant safety concerns.
A century-old redox-active dye repurposed as a mitochondrial enhancer, neuroprotectant, and alternative electron carrier.
A mitochondria-derived peptide that acts as an exercise mimetic, improving glucose metabolism, insulin sensitivity, and cellular stress resilience.
A critical coenzyme in every living cell that declines with age and is central to energy metabolism and DNA repair.
A PEGylated splice variant of IGF-1 that activates muscle satellite cells and promotes muscle repair, with an extended half-life compared to natural MGF.
An FDA-approved melanocortin-4 receptor agonist for hypoactive sexual desire disorder (HSDD) in premenopausal women, acting centrally on the brain rather than peripherally.
An mTOR inhibitor FDA-approved for transplant rejection that has emerged as the most consistently replicated pharmacologic lifespan-extending agent in mammals.
A synthetic heptapeptide anxiolytic developed in Russia by modifying the endogenous immunopeptide tuftsin, offering cognitive enhancement without sedation.
A GLP-1 receptor agonist FDA-approved for type 2 diabetes and chronic weight management that reduces appetite and improves glycemic control.
A synthetic heptapeptide analog of ACTH (4-10) developed in Russia as a nootropic and neuroprotectant, approved there for stroke recovery and cognitive enhancement.
A growth-hormone-releasing hormone analog that stimulates the pituitary to produce GH naturally.
A 43-amino-acid peptide identical to naturally occurring thymosin beta-4 that promotes cell migration, wound healing, and tissue repair.
An FDA-approved GHRH analog specifically indicated for HIV-associated lipodystrophy that reduces visceral adipose tissue while preserving metabolic parameters.
A thymic peptide complex studied for immune reconstitution and longevity, shown to reduce mortality in elderly populations in long-term Russian clinical trials.
An immune-modulating thymic peptide approved in over 35 countries for hepatitis B and as an immune adjuvant, known for enhancing T-cell and dendritic cell function.
A dual GIP/GLP-1 receptor agonist FDA-approved for type 2 diabetes and obesity that achieves greater weight loss than GLP-1 agonists alone.